DoDOC

DoDOC operates as a specialized software-as-a-service (SaaS) platform providing a real-time collaborative editor for writing and reviewing scientific and regulated documents. The company was founded in 2014 by Federico Cismondi, Carlos Boto, and Paulo Melo, who are alumni of the MIT Portugal Program. With headquarters established in Boston, Massachusetts, and a European office in Coimbra, Portugal, DoDOC was developed to address the complex documentation needs of the pharmaceutical and life sciences industries.

The platform's business model is centered on enterprise licenses, targeting primarily pharmaceutical, biotechnology, and medical device companies. Its core service is designed to streamline the document lifecycle, offering features that allow multiple users to collaborate simultaneously, control permissions at a granular level, maintain a complete audit trail of all actions, and automate various tasks. This functionality is engineered to significantly reduce document review times, claiming up to a 70% improvement in efficiency. Key product features include compatibility with Microsoft Word, allowing users to import documents and then leverage DoDOC's tools for collaborative review. The system also incorporates a citation manager that connects with databases like PubMed and Mendeley and can automatically format content to meet specific journal specifications.

DoDOC secured a total of $320K in funding over four rounds from investors including Techstars and Caixa Capital. The company's trajectory shifted significantly in March 2021 when it was acquired by Envision Pharma Group, a global technology and scientific communication company. Following the acquisition, DoDOC became a business unit within Envision, integrated into its iEnvision medical affairs platform while also remaining available as a standalone product. This strategic integration enables Envision to offer a seamless solution for in-line editing of medical affairs documents, enhancing its value proposition to a client base that includes 19 of the top 20 pharmaceutical companies.

Keywords: collaborative authoring, scientific document review, life sciences SaaS, regulatory compliance software, document traceability, clinical documentation, pharmaceutical technology, real-time editing, medical affairs platform, iEnvision, document workflow automation, enterprise collaboration, audit trail, permission control, citation management, Envision Pharma Group, Federico Cismondi, document lifecycle management, biotech software